UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An Updated Comprehensive Review on Diseases Associated with Nephrotic Syndromes

Biomedicines, 2024-10, Vol.12 (10), p.2259

2024

Volltextzugriff (PDF)

Erratum to “Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition” [Kidney International Reports Volume 9, Issue 4, April 2024, Pages 919-928]

Kidney international reports, 2024-10, Vol.9 (10), p.3081-3081

2024

Volltextzugriff (PDF)

Thrombotic thrombocytopenic purpura: 100 years of research on Moschcowitz syndrome

Blood, 2024-09, Vol.144 (11), p.1143-1152

2024

Volltextzugriff (PDF)

On Loss Functionals for Physics-Informed Neural Networks for Steady-State Convection-Dominated Convection-Diffusion Problems

Communications on Applied Mathematics and Computation (Online), 2024-08

2024

Volltextzugriff (PDF)

Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura

The New England journal of medicine, 2024-07, Vol.391 (4), p.382-384

2024

Volltextzugriff (PDF)

Challenges and Considerations in Managing Thrombotic Microangiopathy and Disseminated Intravascular Coagulation in Postpartum Hemorrhage

Kidney international reports, 2024-07, Vol.9 (7), p.2307-2308

2024

Volltextzugriff (PDF)

1491 Management of immune thrombotic thrombocytopenic purpura without therapeutic plasma exchange

Nephrology, dialysis, transplantation, 2024-05, Vol.39 (Supplement_1)

2024

Volltextzugriff (PDF)

Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition

Kidney international reports, 2024-04, Vol.9 (4), p.919-928

2024

Volltextzugriff (PDF)

Personalized, interdisciplinary patient pathway for cross-sector care of multimorbid patients (eliPfad trial): study protocol for a randomized controlled trial

Trials, 2024-03, Vol.25 (1), p.177-177, Article 177

2024

Volltextzugriff (PDF)

Modelling atomic and nanoscale structure in the silicon–oxygen system through active machine learning

Nature communications, 2024-03, Vol.15 (1), p.1927-1927, Article 1927

2024

Volltextzugriff (PDF)

An AI-based 450-kV Computed Tomography Solution for Hairpin Welding Inspection

E-journal of Nondestructive Testing, 2024-03, Vol.29 (3)

2024

Volltextzugriff (PDF)

Antinephrinantikörper als potenzieller Permeabilitätsfaktor bei proteinurischen Nierenerkrankungen

Die Nephrologie, 2024, Vol.19 (1), p.47-49

Völker, Linus Alexander

2024

Volltextzugriff (PDF)

Multiparametric Monitoring of Disease Progression in Contemporary Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy Initiating Tafamidis Treatment

Journal of clinical medicine, 2024-01, Vol.13 (1), p.284

2024

Volltextzugriff (PDF)

Using Deep Neural Networks for Detecting Spurious Oscillations in Discontinuous Galerkin Solutions of Convection-Dominated Convection–Diffusion Equations

Journal of scientific computing, 2023-11, Vol.97 (2), p.36, Article 36

2023

Volltextzugriff (PDF)

Bridging thrombolysis improves survival rates at 90 days compared with direct mechanical thrombectomy alone in acute ischemic stroke due to basilar artery occlusion: a systematic review and meta-analysis of 1096 patients

Journal of neurointerventional surgery, 2023-10, Vol.15 (10), p.1039-1045

2023

Volltextzugriff (PDF)

Five years of caplacizumab – lessons learned and remaining controversies in immune-mediated thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2023-10, Vol.21 (10), p.2718-2725

2023

Volltextzugriff (PDF)

The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer

Nature communications, 2023-09, Vol.14 (1), p.5391-5391, Article 5391

2023

Volltextzugriff (PDF)

Stimulation of Immune Checkpoint Molecule B and T-Lymphocyte Attenuator Alleviates Experimental Crescentic Glomerulonephritis

Journal of the American Society of Nephrology, 2023-08, Vol.34 (8), p.1366-1380

2023

Volltextzugriff (PDF)

Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS

Scientific reports, 2023-04, Vol.13 (1), p.6980-6980, Article 6980

2023

Volltextzugriff (PDF)

Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2023-03, Vol.21 (3), p.559-572

2023

Volltextzugriff (PDF)

Concomitant presentation of thrombotic thrombocytopenic purpura, immune thrombocytopenia, and autoimmune hemolytic anemia in a patient with newly diagnosed systemic lupus erythematosus

Clinical nephrology. Case studies, 2023, Vol.11 (1), p.148-154

2023

Volltextzugriff (PDF)

The E3 Ubiquitin Ligase HUWE1 Is a Central Regulator of Podocyte Homeostasis: FR-PO687

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.511-511

2022

Volltextzugriff (PDF)

Repetitive Administration of Rituximab to Maintain Clinical Remission in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis: SA-PO709

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.798-798

2022

Volltextzugriff (PDF)

Impact of First-Line Use of Caplacizumab on Treatment Outcomes in Immune Thrombotic Thrombocytopenic Purpura: News From the REACT-2020 Cohort: TH-PO506

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.190-190

2022

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Aktive Filter

ThemaMembrane Proteins - Genetics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(54)

Publikationsform

Sprache

Englisch
(60)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(33)
Humans
(20)
Animals
(9)
Female
(9)
Hematology
(9)
Male
(8)
Purpura, Thrombotic Thrombocytopenic - Drug Therapy
(7)
Urology & Nephrology
(7)
Clinical Trials
(5)
Fibrinolytic Agents - Therapeutic Use
(5)
Single-Domain Antibodies
(5)
Technology
(5)
Adamts13 Protein
(4)
Cardiovascular System & Cardiology
(4)
Immunology
(4)
Mice
(4)
Oncology
(4)
Patients
(4)
Peripheral Vascular Disease
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

An Updated Comprehensive Review on Diseases Associated with Nephrotic Syndromes

Management of immune thrombotic thrombocytopenic purpura without therapeutic plasma exchange

Erratum to “Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition” [Kidney International Reports Volume 9, Issue 4, April 2024, Pages 919-928]

Thrombotic thrombocytopenic purpura: 100 years of research on Moschcowitz syndrome

On Loss Functionals for Physics-Informed Neural Networks for Steady-State Convection-Dominated Convection-Diffusion Problems

Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura

Challenges and Considerations in Managing Thrombotic Microangiopathy and Disseminated Intravascular Coagulation in Postpartum Hemorrhage

1491 Management of immune thrombotic thrombocytopenic purpura without therapeutic plasma exchange

Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition

Personalized, interdisciplinary patient pathway for cross-sector care of multimorbid patients (eliPfad trial): study protocol for a randomized controlled trial

Modelling atomic and nanoscale structure in the silicon–oxygen system through active machine learning

An AI-based 450-kV Computed Tomography Solution for Hairpin Welding Inspection

Antinephrinantikörper als potenzieller Permeabilitätsfaktor bei proteinurischen Nierenerkrankungen

Multiparametric Monitoring of Disease Progression in Contemporary Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy Initiating Tafamidis Treatment

Using Deep Neural Networks for Detecting Spurious Oscillations in Discontinuous Galerkin Solutions of Convection-Dominated Convection–Diffusion Equations

Bridging thrombolysis improves survival rates at 90 days compared with direct mechanical thrombectomy alone in acute ischemic stroke due to basilar artery occlusion: a systematic review and meta-analysis of 1096 patients

Five years of caplacizumab – lessons learned and remaining controversies in immune-mediated thrombotic thrombocytopenic purpura

The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer

Stimulation of Immune Checkpoint Molecule B and T-Lymphocyte Attenuator Alleviates Experimental Crescentic Glomerulonephritis

Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS

Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura

Concomitant presentation of thrombotic thrombocytopenic purpura, immune thrombocytopenia, and autoimmune hemolytic anemia in a patient with newly diagnosed systemic lupus erythematosus

The E3 Ubiquitin Ligase HUWE1 Is a Central Regulator of Podocyte Homeostasis: FR-PO687

Repetitive Administration of Rituximab to Maintain Clinical Remission in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis: SA-PO709

Impact of First-Line Use of Caplacizumab on Treatment Outcomes in Immune Thrombotic Thrombocytopenic Purpura: News From the REACT-2020 Cohort: TH-PO506

Aktive Filter

Suchergebnisse filtern